2266. Persistent Inflammation in HIV patients with Community acquired Pneumonia and its Correlation with Lung Injury
Session: Poster Abstract Session: HIV: Opportunistic Infections and other Infectious Complications
Saturday, October 6, 2018
Room: S Poster Hall
Background: HIV patients face higher rates of morbidity compared to the general population, largely due to the earlier development of age related diseases (cardiovascular, kidney, and liver disease). While it is likely that chronic immune activation and inflammation are the main contributors to this process, it’s relation to lung injury in HIV remains unknown. Despite restoration of systemic immune function following Antiretroviral Therapy, the risk for lower respiratory tract infection remain elevated in the HIV population. The objective of the study was to assess the relationship between pulmonary inflammation and lung injury.

Methods: A prospective cohort study was performed, participants include patients hospitalized in Hospital Universitario San Vicente Fundación and Clínica SOMA, in Colombia. Patients were eligible if they were over the age of 18 and had a documented HIV infection or if they have HIV with newly diagnosed community acquired pneumonia (CAP). The main exclusion criteria were chronic lung disease and immunosuppresion that is not due to HIV. Patients belonged to two groups: HIV and HIV + CAP. Plasma, sputum samples and pulmonary function test measurements (PFT) were retrieved within 48 hours of hospital admission and at one month follow up. The concentrations of 13 biomarkers were measured and correlated with PFT values, followed by a comparison between the two groups.

Results: Principle Component Analysis revealed that CCL3, CCL4, BAFF, APRIL and TIMP-1 accounts for the majority of the variation between the two groups. Furthermore Kruskal-Wallis testing demonstrates that BAFF and CCL3 are elevated in the HIV + CAP group, compared to the HIV group (p-value <0.005). Other markers of bacterial translocation and monocyte activation did not differ between these groups. FVC and FEV1 measurements are lower in the HIV + CAP group compared to the HIV group, while FEV1/FVC remain constant.

Conclusion: The results of this study identify a unique constellation of biomarkers in HIV patients with CAP, this constellation of biomarkers consists of pro-inflammatory cytokines and regulators of extracellular matrix remodelling, hinting at the occurrence of an inflammatory and tissue injuring process in the lungs. This is supported by the restrictive ventilation pattern seen in this group of patients.

Ruochen Mao, BSc1, Breanne Head, MSc, PhD Candidate2, Adriana Trajtman, MSc2, Diana Marín, Msc3, Iván Arturo Rodríguez Sabogal, MD4, Ruth Cabrera, Msc(c)5, Lucelly López, PhD(c)5, Jenniffer Rodiño, PhD(c)3, Yudy Aguilar, PhD(c)6, Lázaro Vélez, MD7, Zulma Rueda, MD, PhD8 and Yoav Keynan, MD, PhD2, (1)Medicine, university of manitoba, winnipeg, MB, Canada, (2)Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada, (3)Universidad Pontificia Bolivariana, Medellin, Colombia, medellin, Colombia, (4)Universidad de Antioquia, Medellin, Colombia, Medellin, Colombia, (5)Universidad Pontificia Bolivariana, Medellin, Colombia, Medellin, Colombia, (6)Microbiology School, Universidad de Antioquia, Medellin, Colombia, (7)Universidad de Antioquia, Medellin, Colombia, (8)Universidad Pontificia Bolivariana, Medellin, Colombia


R. Mao, None

B. Head, None

A. Trajtman, None

D. Marín, None

I. A. R. Sabogal, None

R. Cabrera, None

L. López, None

J. Rodiño, None

Y. Aguilar, None

L. Vélez, None

Z. Rueda, None

Y. Keynan, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.